Stocks
Axsome Therapeutics (AXSM) P/FCF US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -38.6 | -13.1 | -26.8 | -24.8 | -23.4 | ||||
| Changes by years, y/y, % | -49% | -66% | -100% | -7% | +58.0% | ||||
Axsome Therapeutics. P/FCF
Axsome Therapeutics. P/FCF, changes, %
Axsome Therapeutics (AXSM) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/FCF | -23.0 | -25.9 | -19.6 | -22.8 | -32.6 | -23.4 | ||
| Changes by years, y/y, % | +46% | -10% | -34% | -19% | +42% | |||
| Changes by quarters, q/q, % | -18% | +12% | -24% | +17% | +43% | |||
